Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure
Sign Up to like & getrecommendations! Published in 2025 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2025.1592
Abstract: This substudy of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) randomized clinical trial investigates the association between cell adhesion molecules and adverse outcomes in chronic heart failure. read more here.
Keywords: adhesion molecules; molecules adverse; heart failure; adverse outcomes ... See more keywords